These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5515417)

  • 41. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
    Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
    [No Abstract]   [Full Text] [Related]  

  • 42. Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinol.
    Sabelli HC; Pedemonte WA; Whalley C; Mosnaim AD; Vazquez AJ
    Life Sci; 1974 Jan; 14(1):149-56. PubMed ID: 4810493
    [No Abstract]   [Full Text] [Related]  

  • 43. An automated assay for brain serotonin.
    Peuler JD; Passon PG
    Anal Biochem; 1973 Apr; 52(2):574-83. PubMed ID: 4698851
    [No Abstract]   [Full Text] [Related]  

  • 44. [Role of the serotoninergic structures of the brain in alcoholism].
    Borisov MM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1094-9. PubMed ID: 7027700
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p-Chlorophenylalanine: a specific depletor of brain serotonin.
    Koe BK; Weissman A
    J Pharmacol Exp Ther; 1966 Dec; 154(3):499-516. PubMed ID: 5297133
    [No Abstract]   [Full Text] [Related]  

  • 47. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
    Iwamoto ET; Ho IK; Way EL
    J Pharmacol Exp Ther; 1973 Dec; 187(3):588-67. PubMed ID: 4797745
    [No Abstract]   [Full Text] [Related]  

  • 48. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 49. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
    Buterbaugh GG; Spratt JL
    J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparison of dose-dependent release of single monoamines from the rat brain by reserpine and oxypertine. Answer to the discussion contribution of M. Knaack and H. Quick to our paper on the different release of norepinephrine, dopamine and serotonin depots as a mode of oxypertine action this J. 41, 105 347 (1970)].
    Kim JS; Hassler R; Bak IJ
    Nervenarzt; 1971 Sep; 42(9):490-1. PubMed ID: 5092940
    [No Abstract]   [Full Text] [Related]  

  • 51. Relationship of brain monoamine and locomotor activity in rats.
    Foldes A; Costa E
    Biochem Pharmacol; 1975 Sep; 24(17):1617-21. PubMed ID: 1191320
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on the metabolism of 5-hydroxytryptamine (serotonin). VI. Hydroxylation and amines in cold-stressed reserpinized rats.
    Gál EM; Heater RD; Millard SA
    Proc Soc Exp Biol Med; 1968 Jun; 128(2):412-5. PubMed ID: 5668503
    [No Abstract]   [Full Text] [Related]  

  • 53. Aldehyde derivatives of indoleamines and the enhancement of their binding onto brain macromolecules by pentobarbital and acetaldehyde.
    Tabakoff B; Ungar F; Alivisatos SG
    Nat New Biol; 1972 Jul; 238(82):126-8. PubMed ID: 4403003
    [No Abstract]   [Full Text] [Related]  

  • 54. On the control of brain serotonin turnover rate by end product inhibition.
    Millard SA; Costa E; Gal EM
    Brain Res; 1972 May; 40(2):545-51. PubMed ID: 4337446
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuronal localization of monoamines in the cerebral ganglia of the snail Helix pomatia.
    Bardessono F; Glacobini E; Stepita-Klauco M
    Brain Res; 1972 Dec; 47(2):427-37. PubMed ID: 4264629
    [No Abstract]   [Full Text] [Related]  

  • 56. [On the question of a "reserpine-like" effect of prenylamine (Segontin)].
    Grobecker H; Palm D; Bak IJ; Schmid B
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):215-6. PubMed ID: 5804244
    [No Abstract]   [Full Text] [Related]  

  • 57. Serotonin turnover in the intact cat brain.
    Barkai A; Glusman M; Rapport MM
    J Pharmacol Exp Ther; 1972 Apr; 181(1):28-35. PubMed ID: 4552068
    [No Abstract]   [Full Text] [Related]  

  • 58. New aspects on the storage of 5-hydroxytryptamine in blood platelets.
    Pletscher A; Da Prada M; Berneis KH; Tranzer JP
    Experientia; 1971 Sep; 27(9):993-1002. PubMed ID: 5116149
    [No Abstract]   [Full Text] [Related]  

  • 59. [Influence of substances that change the serotonin level of the brain on the analgesic effect of promedol in rats].
    Murakhina LK
    Farmakol Toksikol; 1976; 39(1):31-5. PubMed ID: 1082823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antinociceptive activity of morphine after injection of biogenic amines in the cerebral ventricles of the conscious rat.
    Sparkes CG; Spencer PS
    Br J Pharmacol; 1971 Jun; 42(2):230-41. PubMed ID: 5091158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.